Kelly A. Diggs-Andrews, B.S.
, Julie M. Silverstein, M.D.
, and Simon J. Fisher, M.D., Ph.D.
Ms. Diggs-Andrews is currently a senior Ph.D. student in the Molecular Cellular Biology program in the Division of Biology and Biomedical Sciences at Washington University in St. Louis; Dr. Silverstein is currently a clinical fellow and Dr. Fisher is currently an Assistant Professor of Medicine, Cell Biology & Physiology, both in the Division of Endocrinology, Metabolism & Lipid Research, Washington University, St. Louis, MO.
Within the past 12 months, Ms. Diggs-Andrews and Dr. Silverstein report no commercial conflicts of interest; Dr. Fisher has been a member of the Speakers Bureau for Merck. This relationship will not influence his presentation.
This activity is made possible an unrestricted educational grant from .
Estimated time to complete:
Albert Einstein College of Medicine designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit(s)™.
Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Albert Einstein College of Medicine is accredited
by the Accreditation Council for Continuing
Medical Education to provide continuing medical
education for physicians.
Upon completion of this Cyberounds®
, you should be able to:
- Identify the sites in the brain that sense and respond to changes in blood sugar
- Identify some of the key glucose sensing proteins in the brain
- Describe the hierarchy of hormones that are released in response to hypoglycemia
- Discuss the etiology of the impaired counterregulatory response and hypoglycemia unawareness that occurs in people with diabetes
- List some therapeutic interventions shown to reduce the risk of hypoglycemia.